BMC Cancer
- ALWAFAI Z, Beck MH, Fazeli S, Gurtler K, et al
Accuracy of endometrial sampling in the diagnosis of endometrial cancer: a
multicenter retrospective analysis of the JAGO-NOGGO.
BMC Cancer. 2024;24:380.
Eur J Obstet Gynecol Reprod Biol
- NATARAJAN P, Martha Schofield A, Elena Vinturache A, Ruthven S, et al
A comparison of the clinical and histological appearances after treatment of
advanced stage ovarian cancer with PlasmaJet(R) device.
Eur J Obstet Gynecol Reprod Biol. 2024;296:311-315.
Gynecol Oncol
- CHEN W, Xie J, Gao C, Zhang C, et al
Hypertension associated with niraparib in cancer patients: A pharmacovigilance
analysis based on the FAERS database and meta-analysis of randomized controlled
trials.
Gynecol Oncol. 2024;182:108-114.
- CASANOVA J, Duarte GS, da Costa AG, Catarino A, et al
Prognosis of polymerase epsilon (POLE) mutation in high-grade endometrioid
endometrial cancer: Systematic review and meta-analysis.
Gynecol Oncol. 2024;182:99-107.
- CRISTEA MC, Stewart D, Synold T, Ruel N, et al
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with
FRalpha-positive recurrent ovarian, primary peritoneal, fallopian tube, or
endometrial cancer, or triple negative breast cancer.
Gynecol Oncol. 2024;182:124-131.
- FIFE AJ, Najor AJ, Aspir TB, Haines KE, et al
Reduced healthcare access contributes to delay of care in endometrial cancer.
Gynecol Oncol. 2024;182:115-120.
Int J Cancer
- DUUS AH, Hannibal CG, Baandrup L, Zheng G, et al
Prediagnostic use of menopausal hormone therapy and long-term survival of
localized epithelial ovarian cancer: The Extreme study.
Int J Cancer. 2024 Mar 26. doi: 10.1002/ijc.34936.
J Clin Oncol
- MUTLU SUTCUOGLU B, Sutcuoglu O
Interpretation of the EORTC-55954 Trial: Does the Response to Neoadjuvant
Chemotherapy Have an Effect on Disease Outcome?
J Clin Oncol. 2024;42:1204-1205.
- HAN CY, Lu KH, Corrigan G, Perez A, et al
Normal Risk Ovarian Screening Study: 21-Year Update.
J Clin Oncol. 2024;42:1102-1109.
PLoS One
- KANG J, Na K, Kang H, Cho U, et al
Prediction of homologous recombination deficiency from Oncomine Comprehensive
Assay Plus correlating with SOPHiA DDM HRD Solution.
PLoS One. 2024;19:e0298128.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016